STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation
Condition(s) studied
Investigational drug(s) / intervention(s)
Wide Circumferential Pulmonary Vein Antrum Isolation (PVAI): Standard PVI
Pulmonary Vein Antrum Isolation Plus Driver Ablation (PVAI+drivers): Standard PVI + Ablation of drivers in LA and RA
Pulmonary Vein Antrum Isolation Plus Box Isolation of Posterior Wall (PVAI+box): Standard PVI + Electrical isolation of the posterior wall of the left atrium
Study summary
The objective of this study is to compare the efficacy of three different ablation strategies in patients with persistent AF:
1. PV antral isolation alone (PVAI)
2. PV antral isolation plus ablation of drivers (PVAI+drivers)
3. PV antral isolation plus isolation of posterior wall (PVAI+box) All three strategies will employ contemporary catheter ablation technology using more efficient open irrigated tip cooling and contact force sensing.
Eligibility
Primary outcome measure(s)
- Freedom from documented atrial arrhythmia ≥ 30 seconds at 18 months after one ablation procedure on or off antiarrhythmic medications (AAM). — 18 months
Trial sites (32)
| Facility | City | Region | Status |
|---|---|---|---|
| Brigham & Women'S Hosptial Inc. | Boston | Massachusetts | |
| Canberra Heart Rhythm Foundation | Garran | Australian Capital Territory | |
| Royal Adelaide Hospital and Cardiovascular Centre | Adelaide | Australia | |
| Alfred Health | Melbourne | Australia | |
| Royal Melbourne Hospital | Parkville | Australia | |
| Medical University of Graz | Graz | Austria | |
| Ordensklinikum Linz GmbH | Linz | Austria | |
| OLV Hospital Aalst | Aalst | Belgium | |
| Antwerp University Hospital (UZA) | Edegem | Belgium | |
| AZ Sint-Jan | Ruddershove | Belgium | |
| University of Calgary Foothills | Calgary | Alberta | |
| Vancouver General Hospital | Vancouver | British Colombia | |
| St. Paul's Hospital, Vancouver, BC | Vancouver | British Colombia | |
| Royal Jubilee Hospital | Victoria | British Colombia | |
| Hamilton General Hospital | Hamilton | Ontario | |
| Southlake Regional Health Center | Newmarket | Ontario | |
| Laurent Macle | Montreal | QC - Québec | |
| MUHC, McGill University Health Centre | Montreal | Quebec | |
| University of Ottawa Heart Institute | Ottawa | Quebec | |
| Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) | Québec | Quebec | |
| Hôpital Fleurimont, CHUS | Sherbrooke | Quebec | |
| Hospital St-Joseph | Marseille | France | |
| Institut Mutualiste Montsouris | Paris | France | |
| Clinique du Tonkin | Villeurbanne | France | |
| Ospedale Generale Regionale F. Miulli | Acquaviva delle Fonti | Italy | |
| Dokkyo Medical University Koshigaya Hospital | Koshigaya | Saitama | |
| Juntendo University Hospital | Bunkyo City | Tokyo | |
| National University Corporation Kobe University | Chūōku | Japan | |
| Jikei University School of Med | Tokyo | Japan | |
| Minamino Cardiovascular Hospital | Tokyo | Japan | |
| Nihon University School of Medicine | Tokyo | Japan | |
| Hospital Clinic Barcelona | Barcelona | Spain |
More McGill University Health Centre/Research Institute of the McGill University Health Centre trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04428944 on ClinicalTrials.gov ↗ ← All trials in France